Thus, in T2D, a condition with elevated [Ca2+]cyto, both lowering of [Ca2+]cyto by mPTP inhibition as well as further increasing it by MCU inhibition can reduce cell proliferation, suggesting a “sweet spot” or “goldilocks effect” for [Ca2+]cyto to promote proliferation. Here, MCU is linked to type 2 diabetes mellitus.